Psoriasis
Latest News
Approval of Spesolimab for Generalized Pustular Psoriasis Expanded
Spesolimab is an injectable antibody that blocks the IL-36 receptor, a key part of the pathway shown to be involved in the cause of GPP.
Latest News
LITE Study Provides Encouraging Data on Home-Based Phototherapy for Psoriasis
Office-based phototherapy is not available in 90% of counties in the United States, “and a lack of US data has resulted in many insurance...
Latest News
Immunomodulators Do Not Affect COVID-19 Vaccine Efficacy
SMIs and biologics do not reduce efficacy of COVID-19 vaccination, study finds.
Latest News
Sustained Control Reported for Anti–IL-17, Anti–IL-23 Psoriasis Treatments
Longer follow up is with the IL-17 inhibitor bimekizumab. In a 4-year open-label extension study, the PASI 90 rate was approximately 85% in...
Clinical Review
Depression As a Potential Contributing Factor in Hidradenitis Suppurativa and Associated Racial Gaps
Depression may be a potential contributing factor to hidradenitis suppurativa in affected patients,
From the Journals
How Good are Tools to Screen for Spondyloarthritis in Patients With Psoriasis, Uveitis, IBD?
A comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients...
Latest News
Study Evaluates Factors Driving Fatigue in Patients With Psoriasis, PsA
The study “highlights the importance of a symptom-based approach when treating psoriasis, ” the authors wrote.
News from the FDA/CDC
FDA Approves 10th Humira Biosimilar, With Interchangeability
Adalimumab-ryvk (Simlandi) is the first adalimumab biosimilar in a high-concentration formulation to receive interchangeability status from the...
From the Journals
Ixekizumab’s Final Safety Results Reported Across 25 Trials in Psoriasis, PsA, Axial SpA
Final safety results from 25 randomized clinical trials were consistent with previous reports at up to 6 years’ follow-up.
Latest News
Use of Biologics for Psoriasis Found to Confer a Survival Benefit
The study population consisted of 18,618 psoriasis cases and 55,854 controls.
Latest News
Pretreatment Lab Testing for Chronic Skin Diseases Diverges From Guidelines
In the study, a CBC was the most common pretreatment test across treatments, performed in 41%-69% of patients before starting treatment with a...